Regen BioPharma, Inc.
RGBP
$0.01
$0.0020.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -111.49% | -28.59% | 84.16% | -255.69% | 16.71% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 181.43% | -272.09% | 193.02% | 186.36% | -4,766.67% |
| Total Other Non-Cash Items | 63.85% | 18,161.54% | -- | -- | -21.00% |
| Change in Net Operating Assets | 159.35% | -620.85% | -3.62% | 2,077.98% | -281.10% |
| Cash from Operations | 22.82% | 67.56% | 51.65% | 59.09% | -785.90% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 54.32% | -- | -- | -- | -46.11% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 106.38% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 55.81% | -64.17% | -36.83% | -60.31% | 1.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 210.97% | 100.00% | 103.45% | -117.14% | -150.79% |